Skip to main content Accessibility help
×
Home
  • Print publication year: 2013
  • Online publication date: June 2014

Carbamazepine

Related content

Powered by UNSILO

Suggested reading

Callaghan N, Kenny RA, O’Neil B, Crowley M, Goggin T. A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. Journal of Neurology, Neurosurgery, and Psychiatry 1985; 48: 639–644.
Chen P, Lin JJ, Lu CS, et al. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. New England Journal of Medicine 2011; 364: 1126–1133.
Johannessen Landmark C, Patsalos PN. Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Reviews in Neurotheropeutics 2010; 10: 119–140.
Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study. New England Journal of Medicine 1992; 327: 765–771.
McCormack M, Alfirevic A, Bourgeois S, et al. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. New England Journal of Medicine 2011; 364: 1134–1143.
Misra A, Aggarwal A, Singh O, Sharma S. Effect of carbamazepine therapy on vitamin D and parathormone in epileptic children. Pediatric Neurology 2010; 43: 320–324.
Patsalos PN. Antiepileptic drug interactions – A clinical guide. 2nd Edition. 2013, Springer, London, UK; 2013.
Patsalos PN, Berry DJ, Bourgeois BFD, Cloyd JC, Glauser TA, Johannessen SI, Leppik IE, Tomson T, Perucca E. Antiepileptic drugs – Best practice guidelines for therapeutic drug monitoring: a position paper by the Subcommission on Therapeutic Drug Monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008; 49: 1239–1276.
Patsalos PN, Froscher W, Pisani F, van Rijn CM. The importance of drug interactions in epilepsy therapy. Epilepsia 2002; 43: 365–385.
Patsalos PN, Perucca E. Clinically important interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurology 2003; 2: 347–356.
Patsalos PN, Perucca E. Clinically important interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurology 2003; 2: 473–481.
Rambeck B, Salke-Treumann A, May T, Boenigh HE. Valproic acid induced carbamazepine-10,11-epoxide toxicity in children and adolescents. European Neurology 1990; 30: 79–83.